AI drug discovery company
Formation Bio
Data as of .
Company facts
-
Founded
2016
-
Headquarters
United States (New York)
Latest funding round
- Round
- Series D
- Date
- Jun 26, 2024
- Amount
- $372M
- Lead investor
- Andreessen Horowitz (a16z)
Drug discovery partners
0 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Lynk Pharmaceuticals Biotech
In-license of LNK01006 TYK2 inhibitor (ex-China),
Recent news
-
First participant dosed in Phase 1 of BLKR201, in-licensed from Lynk
-
Describes ARK, its MCP-based platform connecting models, systems and agents
-
Licensed LNK01006 CNS-penetrant TYK2 inhibitor from Lynk; Phase 1 planned
-
Licensed Lynk Pharma's TYK2 inhibitor (ex-China)
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.